Carta científico-clínica
Toxicidad cutánea por telaprevir: un nuevo fármaco que es necesario conocer
Skin Toxicity Due to Telaprevir: A New Drug We Should Be Familiar With
M.T. López-Villaescusa
, L.J. Pérez-García, M. Rodríguez-Vázquez, M.L. Martínez-Martínez
Autor para correspondencia
Servicio de Dermatología, Complejo Hospitalario Universitario de Albacete, Albacete, España
Leído
6800
Vecesse ha leído el artículo
2143
Total PDF
4657
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 22 | 3 | 25 |
| 2025 5 | 62 | 32 | 94 |
| 2025 4 | 74 | 26 | 100 |
| 2025 3 | 76 | 13 | 89 |
| 2025 2 | 74 | 33 | 107 |
| 2025 1 | 70 | 23 | 93 |
| 2024 12 | 87 | 32 | 119 |
| 2024 11 | 70 | 40 | 110 |
| 2024 10 | 45 | 40 | 85 |
| 2024 9 | 36 | 20 | 56 |
| 2024 8 | 73 | 57 | 130 |
| 2024 7 | 64 | 32 | 96 |
| 2024 6 | 62 | 28 | 90 |
| 2024 5 | 56 | 26 | 82 |
| 2024 4 | 57 | 21 | 78 |
| 2024 3 | 58 | 24 | 82 |
| 2024 2 | 46 | 25 | 71 |
| 2024 1 | 52 | 26 | 78 |
| 2023 12 | 33 | 15 | 48 |
| 2023 11 | 59 | 29 | 88 |
| 2023 10 | 62 | 18 | 80 |
| 2023 9 | 85 | 27 | 112 |
| 2023 8 | 55 | 14 | 69 |
| 2023 7 | 72 | 28 | 100 |
| 2023 6 | 51 | 23 | 74 |
| 2023 5 | 91 | 23 | 114 |
| 2023 4 | 70 | 19 | 89 |
| 2023 3 | 52 | 23 | 75 |
| 2023 2 | 57 | 18 | 75 |
| 2022 1 | 47 | 31 | 78 |
| 2022 12 | 50 | 35 | 85 |
| 2022 11 | 64 | 36 | 100 |
| 2022 10 | 63 | 29 | 92 |
| 2022 9 | 59 | 40 | 99 |
| 2022 8 | 51 | 64 | 115 |
| 2022 7 | 78 | 38 | 116 |
| 2022 6 | 78 | 28 | 106 |
| 2022 5 | 94 | 39 | 133 |
| 2022 4 | 61 | 27 | 88 |
| 2022 3 | 60 | 46 | 106 |
| 2022 2 | 48 | 23 | 71 |
| 2021 1 | 43 | 39 | 82 |
| 2021 12 | 30 | 37 | 67 |
| 2021 11 | 42 | 35 | 77 |
| 2021 10 | 58 | 51 | 109 |
| 2021 9 | 49 | 34 | 83 |
| 2021 8 | 48 | 27 | 75 |
| 2021 7 | 37 | 36 | 73 |
| 2021 6 | 50 | 31 | 81 |
| 2021 5 | 34 | 30 | 64 |
| 2021 4 | 91 | 48 | 139 |
| 2021 3 | 45 | 21 | 66 |
| 2021 2 | 49 | 24 | 73 |
| 2020 1 | 32 | 24 | 56 |
| 2020 12 | 41 | 9 | 50 |
| 2020 11 | 22 | 9 | 31 |
| 2020 10 | 24 | 19 | 43 |
| 2020 9 | 38 | 13 | 51 |
| 2020 8 | 16 | 19 | 35 |
| 2020 7 | 31 | 13 | 44 |
| 2020 6 | 31 | 19 | 50 |
| 2020 5 | 27 | 27 | 54 |
| 2020 4 | 31 | 15 | 46 |
| 2020 3 | 34 | 15 | 49 |
| 2020 2 | 3 | 1 | 4 |
| 2020 1 | 5 | 2 | 7 |
| 2019 12 | 8 | 0 | 8 |
| 2019 11 | 4 | 4 | 8 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 8 | 0 | 8 |
| 2019 8 | 4 | 2 | 6 |
| 2019 7 | 5 | 4 | 9 |
| 2019 6 | 5 | 2 | 7 |
| 2019 5 | 2 | 7 | 9 |
| 2019 4 | 0 | 3 | 3 |
| 2019 3 | 2 | 6 | 8 |
| 2019 1 | 1 | 3 | 4 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 3 | 1 | 4 |
| 2018 10 | 4 | 1 | 5 |
| 2018 9 | 3 | 0 | 3 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 2 | 2 | 4 |
| 2018 2 | 23 | 4 | 27 |
| 2018 1 | 27 | 4 | 31 |
| 2017 12 | 29 | 5 | 34 |
| 2017 11 | 24 | 5 | 29 |
| 2017 10 | 33 | 12 | 45 |
| 2017 9 | 22 | 5 | 27 |
| 2017 8 | 33 | 4 | 37 |
| 2017 7 | 26 | 4 | 30 |
| 2017 6 | 42 | 24 | 66 |
| 2017 5 | 26 | 10 | 36 |
| 2017 4 | 19 | 8 | 27 |
| 2017 3 | 22 | 18 | 40 |
| 2017 2 | 20 | 11 | 31 |
| 2016 1 | 21 | 9 | 30 |
| 2016 12 | 39 | 6 | 45 |
| 2016 11 | 46 | 12 | 58 |
| 2016 10 | 41 | 25 | 66 |
| 2016 9 | 47 | 9 | 56 |
| 2016 8 | 34 | 8 | 42 |
| 2016 7 | 33 | 5 | 38 |
| 2016 6 | 6 | 12 | 18 |
| 2016 5 | 4 | 5 | 9 |
| 2016 4 | 5 | 2 | 7 |
| 2016 3 | 6 | 6 | 12 |
| 2016 2 | 10 | 2 | 12 |
| 2015 1 | 8 | 5 | 13 |
| 2015 12 | 6 | 5 | 11 |
| 2015 11 | 4 | 1 | 5 |
| 2015 10 | 4 | 3 | 7 |
| 2015 9 | 4 | 4 | 8 |
| 2015 8 | 4 | 1 | 5 |
| 2015 7 | 40 | 3 | 43 |
| 2015 6 | 38 | 7 | 45 |
| 2015 5 | 64 | 4 | 68 |
| 2015 4 | 36 | 4 | 40 |
| 2015 3 | 28 | 2 | 30 |
| 2015 2 | 37 | 5 | 42 |
| 2015 1 | 24 | 4 | 28 |
| 2014 12 | 28 | 6 | 34 |
| 2014 11 | 25 | 6 | 31 |
| 2014 10 | 27 | 3 | 30 |
| 2014 9 | 18 | 4 | 22 |
| 2014 8 | 20 | 8 | 28 |
| 2014 7 | 25 | 4 | 29 |
| 2014 6 | 32 | 7 | 39 |
| 2014 5 | 43 | 14 | 57 |
| 2014 4 | 17 | 17 | 34 |
Mostrar todo
